To support ITMIG, please DONATE
  1. Home
  2. ITMIG Events
  3. ITMIG Webinars

ITMIG Webinars

WEBINARS 2024

WATCH THE RECORDINGS!
Clinical trials for thymic tumors

Moderator: Dr. Chul Kim, Medical Oncologist

Speakers:

  • Dr. Claudia Proto, Medical Oncologist
  • Dr. Jennifer Marks, Medical Oncologist
  • Dr. Clemence Basse, Medical Oncologist

Webinar for Patients

Questions I’d like to ask my doctor

 

Organizer: ITMIG Communication Committee

Patients’ questions submitted before the webinar were answered by doctors:

  • Conrad Falkson, Radiation Oncologist, Queen’s University and CCSEO @ KHSC Kingston, Canada
  • Dirk Van Raemdonck, Thoracic surgeon, University Hospitals Leuven, Belgium
  • Arun Rajan, Medical Oncologist, National Cancer Institute, National Institutes of Health, Bethesda, United States
  • Edith Marom, Diagnostic Radiologist, The Chaim Sheba Medical Center, Ramat Gan, Israel

Moderator: Malgorzata Szolkowska, Pathologist, The Institute of Tuberculosis and Lung Diseases, Warsaw, Poland

Webinars 2023

Webinars organized in May 2023 on the Thymic Malignancy Awareness Month

Free access to recordings - click on the image of chosen webinar

Webinars for Physicians

Clinical Trials for Thymic Epithelial Tumors

Scientific Organizer: ITMIG Communication Committee

Moderator: Chul Kim, Georgetown University, Washington, DC, USA 

PROGRAM:

  1. Meredith McAdams, National Cancer Institute, National Institutes of Health, Bethesda, USA:
    – (NCT05104736) PT-112 in Subjects with Thymoma and Thymic Carcinoma
    – (NCT04417660) Bintrafusp Alfa (M7824) in Subjects with Thymoma and Thymic Carcinoma
  2. Dwight Owen, Ohio State University – James Comprehensive Cancer Center, Columbus, OH, USA: (NCT03463460) Pembrolizumab and Sunitinib in Treating Participants With Refractory Metastatic or Unresectable Thymic Cancer
  3. Chris Nabel, Massachusetts General Hospital Cancer Center, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA: (NCT04262466) Safety and Efficacy of IMC-F106C as a Single Agent and in Combination With Checkpoint Inhibitors
  4. Annemarie Shepherd, Memorial Sloan Kettering Cancer Center, New York, NY, USA: (NCT05354570) A Study of Intensity-Modulated Pleural Radiation Therapy (IMPRINT) in People With Thymic Cancer That Has Spread to the Lining of the Lungs and Chest
  5. Q&A
Joint STR/ITMIG Thymic Imaging Webinar

 

Scientific Organizers: STR and ITMIG

Moderator: Cristina Fuss, MD, PhD, Professor of Radiology, Department of Diagnostic Radiology, Oregon Health & Science University, Portland, OR, USA

PROGRAM:

  1. PET of thymus, Chad Strange, MD, Associate Professor of Radiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA
  2. Thymic disorder mimics: Mediastinal masses, Sanjeev Bhalla, MD, Professor of Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA
  3. Thymic neoplasms CT/MRI: When, how, why? Constantine Raptis, MD, Professor of Diagnostic Radiology, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO, USA
  4. MRI: Your Thymus’ best friend, Jeanne Ackman, MD, Assistant Professor, Harvard Medical School, Massachusetts General Hospital, Boston, MA, USA
  5. Q&A
Webinar in Polish: Grasiczaki i raki grasicy – aktualności w zakresie diagnostyki i leczenia. Prezentacja przypadków i dyskusja wielodyscyplinarna

 

Organizator naukowy: ITMIG Communication Committee

W oparciu o przypadki kliniczno-radiologiczno-histopatologiczne omówiono m.in.:

  • Aktualne zasady oceny stopnia zaawansowania (staging) grasiczaków i raków grasicy według TNM
  • Wskazania i przeciwskazania do chirurgii małoinwazyjnej w guzach śródpiersia
  • Kiedy wykonywać biopsję guza śródpiersia?
  • Miejsce leczenia neoadjuwantowego
  • Radioterapia adjuwantowa – wskazania do leczenia według różnych towarzystw naukowych
  • Kontrola chorych po resekcji guza śródpiersia – jak często, jak długo i jaką metodą?

Moderacja:

Dr n. med. Magdalena Knetki-Wróblewska, Klinika Nowotworów Płuca i Klatki Piersiowej, Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy, Warszawa
Dr hab. n. med. prof. IGiChP Małgorzata Szołkowska, Zakład Patomorfologii, Instytut Gruźlicy i Chorób Płuc, Warszawa

Prelegenci:

  1. Dr n. med. Katarzyna Błasińska, Zakład Radiologii, Instytut Gruźlicy i Chorób Płuc, Warszawa
  2. Dr n. med. Magdalena Knetki-Wróblewska, Klinika Nowotworów Płuca i Klatki Piersiowej, Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie – Państwowy Instytut Badawczy, Warszawa
  3. Dr hab. n. med. Tomasz Marjański, Katedra i Klinika Chirurgii Klatki Piersiowej Gdański Uniwersytet Medyczny, Gdańsk
  4. Dr hab. n. med. prof. IGiChP Małgorzata Szołkowska, Zakład Patomorfologii, Instytut Gruźlicy i Chorób Płuc, Warszawa
  5. Dr n. med. Anna Wrona, Katedra i Klinika Onkologii i Radioterapii Gdański Uniwersytet Medyczny, Gdańsk

Webinars 2022

Webinars organized in May 2022 on the Thymic Malignancy Awareness Month

Webinars for Patients

Organizer: ITMIG Communication Committee

Patients’ questions were answered by doctors:

  • Joshua Sonett, thoracic surgeon, NewYork-Presbyterian/Columbia University Medical Center, New York, USA 
  • Arun Rajan, medical oncologist, National Cancer Institute, National Institutes of Health (NCI/NIH), Bethesda, USA
  • Andreas Rimner, radiation oncologist, Memorial Sloan Kettering Cancer Center, New York, USA
  • Edith Marom, diagnostic radiologist, The Chaim Sheba Medical Center, Ramat Gan, Israel

Moderator: Malgorzata Szolkowska, pathologist, The Institute of Tuberculosis and Lung Diseases, Warsaw, Poland

Organizer: ITMIG Communication Committee

Presenters: 

  • Paul Van Schil, thoracic surgeon, from the Antwerp University Hospital and Antwerp University (Antwerp, Belgium)
  • Frank Detterbeck, thoracic surgeon, from the Yale University School of Medicine (New Haven, CT, USA)
  • Q&A

Webinars for Physicians

Scientific Organizer: Giuseppe Cardillo, Chief of Thoracic Surgery, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy

Technical Organizer: ITMIG Communication Committee

Program: 

Moderator: Giuseppe Cardillo (Italy)

  • Introduction, Giuseppe Cardillo (Italy)
  • The surgeon’s needs, Enrico Ruffini (Italy)
  • The pathological boundaries of the TNM classification, Anja Roden (USA)
  • The radiologist’s view, Edith Marom (Israel)
  • The oncologist’ s perspective, Nicolas Girard (France)
  • Towards the 9th edition, Thierry Molina (France)
  • Q&A

Scientific Organizer: Mirella Marino, IRCCS Regina Elena National Cancer Institute, Rome, Italy

Technical Organizer: ITMIG Communication Committee

Program: 

Moderator: Mirella Marino, IRCCS Regina Elena National Cancer Institute, Rome, Italy

  • Rebuilding the human thymus complexity, Paola Bonfanti, The Francis Crick Institute and UCL, London, UK
  • An overview of laboratory tools in thymic epithelial tumors research, Mirella Marino, IRCCS Regina Elena National Cancer Institute, Rome, Italy
  • Molecular pathology meets oncology, Alexander Marx, Universitätsklinikum Mannheim GmbH, Mannheim, Germany
  • Mediastinal lymphomas vs. thymomas: a source of diagnostic pitfalls, Lucia Anemona, University of Rome, Tor Vergata, Rome, Italy
  • Good’s syndrome: new insights, Giovannella Palmieri, CRCTR Coordinating Rare Tumors Reference Center of Campania Region, Naples, Italy
  • Q&A

Webinar Committee

Main organizers: 

Malgorzata Szolkowska – pathologist, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Pam Bruce, Executive Director of ITMIG, New York, USA

Edith Marom – diagnostic radiologist, The Chaim Sheba Medical Center, Ramat Gan, Israel

 

Our webinars could not appear without help of the following experts:

(in alphabetical order)

Katarzyna Blasinska – diagnostic radiologist, Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Frank Detterbeck – thoracic surgeon, Yale University School of Medicine, New Haven, CT, USA

Conrad Falkson – radiation oncologist, Queen’s University and Kingston Health Sciences Center, Kingston, Ontario, Canada

Nicolas Girard – medical oncologist, Institut Curie, Paris, France

Maria Isabel Leite – neurologist, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK

Arun Rajan – medical oncologist, National Cancer Institute, National Institutes of Health (NCI/NIH), Bethesda, USA

Andreas Rimner – radiation oncologist, Memorial Sloan Kettering Cancer Center, New York, USA

Anja Roden – pathologist, Mayo Clinic Rochester, Rochester, MN, USA

Paul van Schil – thoracic surgeon, Antwerp University Hospital, Edegem (Antwerp), Belgium

Webinars 2021

Webinars for Patients: 

Series: EXPERTS EXPLAIN

Part 1: Imaging of thymic tumors. How should I understand my diagnosis?

Part 2: Surgical treatment of mediastinal tumours: from maximally invasive to minimally invasive techniques

Part 3: Radiotherapy of thymic epithelial tumors

Part 4: Oncological Treatment for Advanced Thymic Tumors – Definitions and Strategies

Part 5: Clinical Trials for Thymic Epithelial Tumors

Webinars 2020

Webinar for Patients: 

The questions I would like to ask my doctor

Webinars for Physicians: 

Series: Diagnosis and Treatment of Thymic Epithelial Tumors

Webinar Committee

Main organizers: 

Malgorzata Szolkowska – pathologist, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Pam Bruce, Executive Director of ITMIG, New York, USA

Edith Marom – diagnostic radiologist, The Chaim Sheba Medical Center, Ramat Gan, Israel

 

Our webinars could not appear without help of the following experts:

(in alphabetical order)

Katarzyna Blasinska – diagnostic radiologist, Department of Radiology, National Tuberculosis and Lung Diseases Research Institute, Warsaw, Poland

Frank Detterbeck – thoracic surgeon, Yale University School of Medicine, New Haven, CT, USA

Conrad Falkson – radiation oncologist, Queen’s University and Kingston Health Sciences Center, Kingston, Ontario, Canada

Nicolas Girard – medical oncologist, Institut Curie, Paris, France

Maria Isabel Leite – neurologist, Nuffield Department of Clinical Neurosciences, John Radcliffe Hospital, Oxford, UK

Arun Rajan – medical oncologist, National Cancer Institute, National Institutes of Health (NCI/NIH), Bethesda, USA

Andreas Rimner – radiation oncologist, Memorial Sloan Kettering Cancer Center, New York, USA

Anja Roden – pathologist, Mayo Clinic Rochester, Rochester, MN, USA

Paul van Schil – thoracic surgeon, Antwerp University Hospital, Edegem (Antwerp), Belgium

Last update May 2022

ITMIG

Privacy Policy